ResultsIQ › Latest results › Mahamaya Lifesciences Ltd
Mahamaya Lifesciences Ltd investor presentation summary
NSE: MAHALIFE · BSE: 544611
Investor presentation of 7 Aug 2026, summarised by AI from the filing.
Mahamaya Lifesciences filed its investor meet presentation with BSE; the meet is on August 07, 2026, from 04:00 pm IST.
Key takeaways
- Investor meet The investor meet is scheduled for Friday, August 07, 2026, from 04:00 pm (IST) onwards.
- Presentation The investor presentation to be shared at the meet is available on the company's website.
- Disclosure The presentation is shared for dissemination of information and does not contain any unpublished price sensitive information.
- Filing The filing is under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of Schedule III.
- Signatory Krishnamurthy Ganesan, Managing Director, DIN: 00270539, signed the filing for Mahamaya Lifesciences Limited.
Mahamaya Lifesciences Ltd earnings call, investor presentation and press release summaries
- Q4 FY26: Results press release (26 May 2026)
- Other events: Investor presentation (7 Aug 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.